Home » Regions » Global News » La Jolla Institute, Kyowa Hakko Kirin extend research collaboration

La Jolla Institute, Kyowa Hakko Kirin extend research collaboration

Thursday, August 1, 2013

La Jolla Institute for Allergy and Immunology and Kyowa Hakko Kirin California (KKC), a global specialty pharmaceutical company, have signed a new partnership agreement through the end of 2018.

The six-year agreement continues a research alliance founded in 1988 between La Jolla Institute, an academic nonprofit, and KKC, one of Kyowa Hakko Kirin’s R&D centers in the U.S. The collaboration leverages the pharmaceutical company’s discovery and development capabilities and La Jolla Institute’s expertise in basic research to accelerate translation of research discoveries into potential new treatments.

La Jolla Institute will receive a combination of discretionary research funding and funds dedicated to specific projects to be selected by a steering committee of La Jolla Institute and Kyowa Hakko Kirin leaders. KKC will receive first rights of negotiation to pursue translation of La Jolla Institute discoveries, stemming from research projects funded by KKC.

Looking for more news, check out the new FREE CenterWatch Weekly!

The new FREE CenterWatch Weekly is your source of critical news, emerging trends, and business issues around everything in the rapidly changing clinical research marketplace. Check out our new CWWeekly page! Sign up today for your free email newsletter, update your bookmarks and check us out regularly! We look forward to bringing you the best news and information about clinical research in 2018!